Clinical trial
An Extension Study of LON002 in Patients With Cancer
NCT02390986 is registered in ClinicalTrials.gov with LondonPharma Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Extension Study of LON002 in Patients With Cancer
- Lead sponsor
- LondonPharma Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- June 30, 2017
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumours